The Department of Health and Human Services is aware of 20 pharmaceutical products made or with a critical active ingredient solely sourced in China, but to date is not aware of any expected shortages, HHS Secretary Alex Azar told House appropriators today. He said the agency knows of two pharmaceutical makers in Hubei Province, the epicenter of the novel coronavirus (COVID-19) outbreak, but they have a large stockpile supply of advance production.

For the first time since the outbreak started, more new cases are being reported outside China than from China, the World Health Organization said today. While China continues to have the most cases overall, there are now confirmed COVID-19 cases on every continent except Antarctica, totaling more than 81,000 in 37 countries.

The Centers for Disease Control and Prevention continues to update resources, including interim guidance for businesses and employers to plan and respond to COVID-19.

For the latest information and resources, visit AHA’s coronavirus webpage.

Related News Articles

Headline
A Washington resident recently hospitalized with the H5N5 strain of bird flu died Nov. 21, according to the Washington State Department of Health. The…
Headline
Flu cases are growing or likely growing in 39 states, according to the latest Centers for Disease Control and Prevention data from Nov. 11. COVID-19…
Headline
The Washington State Department of Health announced Nov. 14 that a state resident hospitalized earlier this month is the first human to have the H5N5 strain of…
Headline
There have been 1,681 confirmed cases of measles in the U.S. so far this year, according to the latest Centers for Disease Control and Prevention data. Cases…
Headline
A study published Oct. 30 by the American Heart Association found that people have an elevated risk of heart attack and stroke following flu and COVID-19…
Headline
The Centers for Disease Control and Prevention released an advisory Oct. 29 on three unrelated cases of clade I mpox recently identified in California. The…